Compounds for reducing lactation and improving health
OwnerLex DE BOER, Martin Jan HOEKSTRAinventors
Life of this patent
Estimating the term…
Abstract
Preferred compounds include di-n-propyl disulfide, di-methyl disulfide, di-ethyl disulfide, di-isopropyl disulfide, di-n-butyl-disulfide, di-benzyl disulfide, di-ethyl sulfide, di-n-propyl sulfide, di-isopropyl sulfide, di-n-butyl sulfide, di-phenyl sulfide, di-benzyl sulfide, di-n-propyl trisulfide, di-n-propyl sulfone, di-benzyl thiosulfinate, di-benzyl thiosulfonate, di-isopropyl thiosulfonate, di-n-propyl thiosulfonate (PTSO), and di-n-propyl thiosulfinate (PTS).
Claims22
1-10. (canceled)
A method for reducing lactation in a mammal;
- for prophylactic treatment of intramammary infections and/or for reducing the occurrence of dry-off related stress, dry-off related inflammation, or dry-off related infections in a mammal;
- or for promoting the health and well-being of a lactating mammal, comprising administering to a lactating mammal a pharmaceutical or veterinary composition or functional food composition comprising a compound according to Formula II
- wherein
- R1 and R2 are independently selected from the group consisting of C1-4 alkyl, phenyl, and benzyl;
- Q1 is selected from the group consisting of —S—S—, —S—, —S—S—S—, —S(O)2—, —S(O)—S—, and —S(O)2—S—;
- provided that the compound according to Formula II is not diphenyl disulfide.
The method e according to claim 1, wherein the compound is formulated as a single dose unit comprising at least 50 grams.
A pharmaceutical or veterinary composition or functional food composition comprising a compound according to Formula II
- wherein
- R1 and R2 are independently selected from the group consisting of C1-4 alkyl, phenyl, and benzyl;
- Q1 is selected from the group consisting of —S—S—, —S—, —S—S—S—, —S(O)2—, —S(O)—S—, and —S(O)2—S—;
- provided that the compound according to Formula II is not diphenyl disulfide.
Dependencies are inferred from the claim text.